Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature

Evaluation of immunoglobulin replacement therapy in secondary immunodeficiency at three British Columbia hospitals

(2023) Ann Tran et al.   VOX SANGUINIS

Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study

(2022) Paul K. Keith et al.   Allergy Asthma and Clinical Immunology

Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies

(2022) Roger H Kobayashi et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study

(2022) Bruce Ritchie et al.   Allergy Asthma and Clinical Immunology

Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes

(2022) Rajiv Mallick et al.   Allergy Asthma and Clinical Immunology

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia

(2021) Manraj N. Kaur et al.   Blood Advances

Delivery of subcutaneous immunoglobulin by rapid “push” infusion for primary immunodeficiency patients in Manitoba: a retrospective review

(2020) Graham Walter et al.   Allergy Asthma and Clinical Immunology

Chronic immunoglobulin maintenance therapy in myasthenia gravis

(2020) M. Alcantara et al.   EUROPEAN JOURNAL OF NEUROLOGY

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial

(2020) Donald M Arnold et al.   Lancet Haematology

Trends in IVIG use at a tertiary care Canadian center and impact of provincial use mitigation strategies: 10‐year retrospective study with interrupted time series analysis

(2019) Malia S.Q. Murphy et al.   TRANSFUSION

Appropriateness of intravenous immunoglobulin use in immune thrombocytopenia (ITP): A Canadian centre deep dive audit

(2019) Jiajia Liu et al.   TRANSFUSION AND APHERESIS SCIENCE

Impact of IVIG vs. SCIG on IgG trough level and infection incidence in primary immunodeficiency diseases: A systematic review and meta-analysis of clinical studies

(2019) Pragya Shrestha et al.   World Allergy Organization Journal

Home-based subcutaneous immunoglobulin therapy vs hospital-based intravenous immunoglobulin therapy: A prospective economic analysis

(2018) Lisa W. Fu et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Abstract of the 35th international congress of the ISBT

(2018)   VOX SANGUINIS

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

(2018) Andrea C. Tricco et al.   ANNALS OF INTERNAL MEDICINE

Evaluation of a Personalized Subcutaneous Immunoglobulin Treatment Program for Neurological Patients

(2018) Adam Suleman et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement

(2017) Vicki Modell et al.   IMMUNOLOGIC RESEARCH

Update on the use of immunoglobulin in human disease: A review of evidence

(2017) Elena E. Perez et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Quality of Life, Treatment Beliefs, and Treatment Satisfaction in Children Treated for Primary Immunodeficiency with SCIg

(2017) Serge Sultan et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Audit of provincial IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres

(2017) A. W. Shih et al.   TRANSFUSION MEDICINE

Clinical Profile, Dosing, and Quality-of-Life Outcomes in Primary Immune Deficiency Patients Treated at Home with Immunoglobulin G: Data from the IDEaL Patient Registry

(2017) Sean Kearns et al.   Journal of Managed Care & Specialty Pharmacy

An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia

(2016) Naushin S. Sholapur et al.   TRANSFUSION

Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study

(2016) P. R. Bourque et al.   PLoS One

Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015

(2015) Capucine Picard et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Home-Based Subcutaneous Immunoglobulin Versus Hospital-Based Intravenous Immunoglobulin in Treatment of Primary Antibody Deficiencies: Systematic Review and Meta Analysis

(2012) Hassan Abolhassani et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Trimming the fat with an IVIG approval process

(2012) Signy Chow et al.   TRANSFUSION AND APHERESIS SCIENCE

Intravenous immunoglobulin: Adverse reactions and management

(2008) Francisco A. Bonilla   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY